Brief: Molecular Templates Inc Says On Oct 15, Co Received Termination Notice From Vertex Pharmaceuticals
Oct 18 (Reuters) - Molecular Templates Inc MTEM.O :
* MOLECULAR TEMPLATES INC SAYS ON OCTOBER 15, CO RECEIVED
TERMINATION NOTICE FROM VERTEX PHARMACEUTICALS - SEC FILING
* MOLECULAR TEMPLATES INC SAYS VERTEX DECIDED TO TERMINATE
CO'S
MASTER COLLABORATION AGREEMENT BY AND BETWEEN CO AND VERTEX,
DATED NOVEMBER 18, 2019
* MOLECULAR TEMPLATES INC SAYS TERMINATION OF COLLABORATION
AGREEMENT WITH VERTEX WILL BE EFFECTIVE ON OCTOBER 29
Source text for Eikon: [https://bit.ly/3jeV5uG]
Further company coverage: MTEM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Molecular Templates
See all newsBrief: Molecular Templates Co & Affiliate Commenced Chapter 11 Cases As DIP
Brief: Molecular Templates's Eric E. Poma Resigns As CEO, CSO, Treasurer, And Interim CFO
Brief: Molecular Templates Announces Notice Of Delisting And Failure To Satisfy Continued Listing Rules
Brief: Molecular Templates Announces Receipt Of Expected Notification Of Deficiency From Nasdaq
Brief: Molecular Templates Approved Liquidation & Wind Up Through A Dissolution